Clinical Trial Update: Cost-effectiveness of Different Antiretroviral Treatment in Patients HIV Naive [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the cost-effectiveness of different antiretroviral regimens in ART-naive HIV patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Juan A. Arnaiz | Conditions: Patient Compliance, Antiretroviral Therapy Intolerance | Phase 4 | Status: WITHDRAWN